These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8787476)

  • 1. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
    Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes TE; Fagerhol MK; Venge P
    Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
    Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
    Ann Thorac Surg; 2000 Mar; 69(3):743-9. PubMed ID: 10750754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
    Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
    Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
    Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
    Borowiec JW; Hagman L; Tötterman TH; Pekna M; Venge P; Thelin S
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):167-74. PubMed ID: 8789469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.
    Videm V; Mollnes TE; Fosse E; Mohr B; Bergh K; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):794-802. PubMed ID: 10096976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
    Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
    Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
    Lundblad R; Moen O; Fosse E
    Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.